STOCKSCREENR
Log In

LH

NYSE

Labcorp Holdings Inc.

$270.62+3.77(+1.41%)Mkt Cap: $22.43B

Key Stats

Market Cap

$22.43B

P/E Ratio

25.85

EPS

$10.47

Dividend Yield

1.07%

52-Week Range

$209.38 — $293.72

Volume

522.57K

Avg Volume

705.94K

Beta

0.97

Valuation

P/E (TTM)

25.85

Forward P/E

15.15

PEG Ratio

9.30

P/S (TTM)

1.60

P/B (TTM)

2.58

P/FCF

85.04

EV/EBITDA

52.81x

EV/Sales

—

Financial Health

ROE (TTM)

0.10%

ROA (TTM)

0.05%

ROIC

0.03%

Gross Margin

0.28%

Operating Margin

0.11%

Net Margin

0.07%

Debt/Equity

0.84

Current Ratio

1.42

Growth

EPS Growth (YoY)

+0.56%

Revenue Growth (YoY)

+0.10%

EPS Growth (3Y)

-0.08%

EPS Growth (5Y)

+0.24%

Sales Growth (3Y)

-0.00%

Sales Growth (5Y)

+0.03%

EPS Est (This Year)

$17.86

EPS Est (Next Year)

$19.34

Dividends

Dividend Yield

—

Annual Dividend

$0.72

Payout Ratio

0.23%

Frequency

—

Ex-Dividend Date

2025-11-26

Cash/Share

$6.45

Analyst Consensus

1.0

Strong Buy

1 = Strong Buy, 5 = Strong Sell

Price Target Range

$290.00$320.00$342.00
LowMedianHigh

Consensus Target: $315.38(16.5% upside)

Ownership

Institutional %

—

Inst. Net Change

—

Insider Net Shares (90d)

—

Outstanding Shares

82.90M

Float

82.10M

Free Float %

99.04%

Technicals

RSI (14)

66.00

SMA 20

$270.66

SMA 50

$262.82

SMA 200

$265.90

ATR (14)

5.79

Volatility (Week)

0.02%

Volatility (Month)

0.01%

Pattern

—

Performance

1 Day

+3.83%

1 Week

+4.52%

1 Month

+12.98%

3 Months

+12.58%

6 Months

+6.29%

1 Year

—

YTD

+13.05%

All-Time High

$293.72

About

Sector

Healthcare

Industry

Medical - Diagnostics & Research

Country

US

Exchange

NYSE

IPO Date

1990-03-29

Employees

60900

CEO

Adam H. Schechter

Index Membership

S&P 500

Website

https://www.labcorp.com

Labcorp Holdings Inc. (LH) is a healthcare company in the medical - diagnostics & research industry listed on the NYSE. With a market capitalization of $22.43B, a P/E ratio of 25.85, and a dividend yield of 1.07%, LH is tracked by stockscreenr alongside 25,000+ other tickers. Use the free stock screener to compare LH against other stocks using dozens of fundamental and technical filters.

Similar Stocks

0KHE.L

Revvity, Inc.

$88.87

+3.35%

$9.89B

ILMN

Illumina, Inc.

$120.84

+1.31%

$18.48B

NTRA

Natera, Inc.

$198.38

+0.35%

$28.12B

MEDP

Medpace Holdings, Inc.

$455.15

+0.33%

$12.92B

RDNT

RadNet, Inc.

$63.63

-0.73%

$4.94B

0QNO.L

Lonza Group AG

$480.00

-0.64%

$33.60B

Frequently Asked Questions

What is Labcorp Holdings Inc.'s P/E ratio?

Labcorp Holdings Inc. (LH) has a trailing twelve-month (TTM) P/E ratio of 25.85. This is near the market average range. The P/E ratio measures how much investors are willing to pay per dollar of earnings.

Does Labcorp Holdings Inc. pay a dividend?

No, Labcorp Holdings Inc. (LH) does not currently pay a regular dividend. The company may be reinvesting profits into growth, research, or debt reduction instead of returning cash to shareholders through dividends.

What is Labcorp Holdings Inc.'s market cap?

Labcorp Holdings Inc. (LH) has a market capitalization of $22.43 billion, classifying it as a large-cap company. Market cap is calculated by multiplying the current share price by the total number of outstanding shares.

What do analysts think about LH?

Wall Street analysts have a consensus "Strong Buy" rating on Labcorp Holdings Inc. (LH) with an average score of 1.00 on a 1-5 scale (1 = Strong Buy, 5 = Strong Sell). The consensus price target of $315.38 implies 16.5% upside from the current price.

How has LH performed this year?

Labcorp Holdings Inc. (LH) has returned +13.05% year-to-date. Past performance does not guarantee future results, but these figures reflect the stock's recent price trajectory relative to the broader market.